Infant methionine synthase variants and risk for spina bifida

Editor—The mechanisms underlying the reduction in risk for neural tube defect (NTD) affected pregnancies by maternal folic acid supplementation are unknown. Current research efforts are focusing on candidate genes that encode enzymes involved in folate metabolism. Since homocysteine levels have been raised in some women who delivered infants with NTDs,1 2 the enzymes involved in both folate and homocysteine metabolism have received particular attention. Some, but not all, epidemiological data suggest an association between the C677T mutation in methylenetetrahydrofolate reductase (MTHFR) and increased risk for NTDs.3-6 No association between mutations in cystathionine β synthase and NTD risk has been observed.7 The epidemiological data pertaining to genetic variants of methionine synthase are quite limited.8 9 Methionine synthase catalyses the methylation of homocysteine to methionine using 5-methyltetrahydrofolate, the product of the MTHFR reaction, as the carbon donor. Thus, the investigation of genetic variants of methionine synthase is a prudent area of enquiry for exploring …

[1]  G. Shaw,et al.  Maternal vitamin use, genetic variation of infant methylenetetrahydrofolate reductase, and risk for spina bifida. , 1998, American journal of epidemiology.

[2]  E. Mariman,et al.  Methionine synthase and neural tube defects. , 1997, Journal of medical genetics.

[3]  H. Blom,et al.  Sequence analysis of the coding region of human methionine synthase: relevance to hyperhomocysteinaemia in neural-tube defects and vascular disease. , 1997, QJM : monthly journal of the Association of Physicians.

[4]  B. Shane,et al.  Human Methionine Synthase , 1997, The Journal of Biological Chemistry.

[5]  D. Weir,et al.  Are common mutations of cystathionine β‐synthase involved in the aetiology of neural tube defects? , 1997, Clinical genetics.

[6]  P. Goyette,et al.  Human methionine synthase: cDNA cloning and identification of mutations in patients of the cblG complementation group of folate/cobalamin disorders. , 1996, Human molecular genetics.

[7]  J. Mills,et al.  Methylenetetrahydrofolate reductase mutation and neural tube defects , 1996, The Lancet.

[8]  G. Shaw,et al.  Parental cigarette smoking and risk for congenital anomalies of the heart, neural tube, or limb. , 1996, Teratology.

[9]  M. den Heyer,et al.  Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida , 1995, The Lancet.

[10]  G. Shaw,et al.  Risks of orofacial clefts in children born to women using multivitamins containing folic acid periconceptionally , 1995, The Lancet.

[11]  J. Mills,et al.  Homocysteine metabolism in pregnancies complicated by neural-tube defects , 1995, The Lancet.

[12]  H. Blom,et al.  Maternal hyperhomocysteinemia: a risk factor for neural-tube defects? , 1994, Metabolism: clinical and experimental.